查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1863137

全球避孕器材市场：洞察、竞争格局及至2032年预测

Contraceptive Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

避孕器材市场摘要

  • 全球避孕器市场预计将从 2024 年的 202.4583 亿美元成长到 2032 年的 327.6349 亿美元，反映出强劲且持续的成长。
  • 全球避孕器市场在 2025 年至 2032 年的预测期内将以 6.28% 的复合年增长率成长。
  • 全球避孕器市场成长主要受以下几个关键因素驱动。首先，人们对计划生育的认识和教育程度的提高推动了市场需求。其次，人口结构和生活方式的改变，例如生育年龄延迟和女性赋权，增加了对有效避孕解决方案的需求。第三，技术进步，例如长效可逆避孕方法（LARCs）和副作用较少的避孕产品的研发，吸引了更多使用者。最后，政府的支持措施使避孕更加便利和经济实惠，进一步促进了市场扩张。
  • 在避孕器材市场运作的主要企业包括 Reckitt Benckiser Group PLC、Church & Dwight Co., Inc.、Organon & Co.、Bayer AG、CooperSurgical, Inc.、Mankind Pharma Ltd.、HLL Lifecare Limited、Karex Berhad、Okamoto Industries Inc.、Verkind Pharma Ltd.、HLL Lifecare Limited、Karex Berhad、Okamoto Industries Inc.、Veru Inc.、Pregnamed 和 Kcare Limited、Karex Berhad、Okamoto Industries Inc.、Veru Inc.、Pregna。
  • 由于消费者对更高避孕效果和更少副作用的需求不断增长，北美避孕器市场正在蓬勃发展，长效可逆避孕方法（LARCs）和非荷尔蒙避孕方式越来越受到偏好。政府的利好政策，例如《平价医疗法案》（ACA），透过强制医保覆盖避孕产品，进一步推动了这一趋势，提高了避孕产品的可及性。此外，数位医疗和远端医疗服务的日益普及，也使得资讯和处方更容易取得，尤其惠及新一代消费者。
  • 根据产品类型，预计到 2024 年，保险套将占据最大的市场份额。

避孕器材市场成长要素

  • 计划生育意识的提高和避孕器需求的成长正在推动市场扩张。尤其是在开发中国家和新兴市场国家，计划生育意识的提高和避孕器需求的成长是市场扩张的主要驱动力。这一趋势是由各相关人员的共同努力所推动的。
  • 政府措施：许多政府，特别是人口成长率高的国家，都已实施国家计划生育政策和计画。这些措施通常包括进行教育宣传活动，向公民普及避孕对自身健康和社会经济福祉的益处。透过提供多种避孕方法，并在某些情况下提供免费或补贴，政府积极创造并满足了市场需求。
  • 非政府组织和公共卫生团体：非政府组织（NGO）透过提供社区教育和服务发挥重要作用，其服务对象往往是政府计画难以充分覆盖的边缘化群体和农村人口。这些组织致力于消除文化和社会障碍，提供准确资讯以消除关于副作用的误解，并培训卫生工作者以扩大避孕选择范围。
  • 媒体与数位平台：透过大众媒体、社群媒体和数位健康应用程式传播讯息，使得性与生殖健康知识比以往任何时候都更容易获得。这种获取途径的增加，增强了个人，尤其是年轻人，在健康和计划生育方面做出知情选择的能力，从而提高了现代避孕方法的普及率。
  • 社会经济因素：随着教育程度的提高和女性自主权的增强，她们更倾向于推迟或调整生育年龄，以便抓住教育和职业发展的机会。这直接增加了对有效可靠避孕措施的需求。同样，新兴市场中产阶级的崛起提高了可支配收入，使他们能够购买现代化的、通常价格较高的避孕方法，从而进一步推动了市场成长。
  • 技术进步与产品创新：技术进步和产品创新是避孕器市场成长的关键驱动力，因为它们解决了现有的局限性，并为消费者和製造商创造了新的机会。
  • 长效可逆避孕法（LARCs）：由于其高效率、便利性和持久的避孕效果，消费者越来越偏好选择长效可逆避孕方法，例如子宫内避孕器和皮下植入。这些避孕器无需每日或每週服用避孕药，因此对许多使用者来说极具吸引力。
  • 新产品开发：製造商正在投资研发，以开发创新、用户友好的设备，包括推出客製化保险套、新的含激素和非含激素产品，以及可与数位健康平台整合进行监测的「智慧」设备。
  • 减少副作用：新产品研发的一个重点是减少与荷尔蒙避孕相关的常见副作用，例如体重增加、头痛和月经变化。这吸引了一群关注这些议题的新用户群。
  • 政府措施和资金投入：许多政府，特别是人口成长率高的国家，都已实施国家计划生育政策和计画。这些措施通常包括进行教育宣传活动，向公民普及避孕对自身健康和社会经济福祉的益处。
  • 国家人口控制政策：在许多国家，尤其是在亚洲和非洲，政府实施了旨在控制和稳定人口的政策和方案。这些措施通常包括补贴或免费发放避孕药具，从而提高避孕药具的可近性和可负担性。
  • 医疗保健支援：政府资助的卫生计划，如印度的国家卫生任务，已将避孕作为公共卫生战略的组成部分，包括培训卫生工作者提供计划生育咨询和服务，包括子宫内避孕器植入。
  • 官民合作关係：政府和非政府组织越来越多地与私营部门合作，以扩大计划生育服务的覆盖范围，并透过各种管道（包括公共诊所、私人药房和社区卫生工作者）确保在都市区和农村地区都能获得避孕器。

避孕器材市场报告细分

《避孕器材市场报告》全面概述了全球避孕器材市场，重点分析了关键趋势、成长驱动因素、挑战和机会。报告按产品类型、性别、分销管道和地区进行了详细的市场细分，并深入剖析了北美、欧洲和亚太等主要市场的竞争格局、监管环境和市场动态。报告详细介绍了行业领导者的概况和最新的产品创新，为企业提供了识别市场潜力、制定策略规划以及把握快速成长的避孕器市场新机会所需的重要数据。

避孕器，也称为节育措施，是指旨在防止怀孕的装置或製剂。这些装置的作用机制多种多样，例如形成物理屏障阻挡精子、释放抑制排卵的激素，或在子宫内创造不利于精子和受精卵生存的环境。

全球避孕市场受多种关键因素驱动。首先，公共卫生宣传活动以及人们对预防意外怀孕和性行为感染感染（STI）日益增长的关注，透过提高人们对计划生育和生殖健康的认识和教育，推动了市场需求。其次，人口结构和生活方式的改变扮演重要角色。诸如延迟生育、女性赋权以及计划生育责任的共同承担等趋势，都促使人们对有效的避孕解决方案的需求增加。第三，技术进步和产品创新，例如高效长效可逆避孕方法（LARCs，如子宫内避孕器和植入）以及副作用更少的产品的研发，吸引了更多用户。最后，许多国家的政府支持和资金投入，透过公共卫生计画和补贴，使避孕服务更加普及和经济实惠，进一步推动了市场扩张。

全球避孕器材市场预计在预测期内（至 2025 年）将以约 6.8% 的强劲复合年增长率成长。

主要结构性驱动因素是避孕方式持续向长效可逆避孕方法（LARC）、现代子宫内避孕器和皮下植入转变，这些方法因其卓越的疗效、便利性和临床医生更高的熟悉度，正在许多市场取代（或补充）短效、依赖使用者的避孕方法。采购和运输数据显示，LARC 的供应量同比显着增长（儘管在近期的公共部门週期中，铜子宫内避孕器和植入的采购量也有所增加）。

联合国人口基金及其相关伙伴关係报告称，在 2023 年至 2024 年期间，他们支持大规模分发和政府采购。同时，分级定价和社交行销管道正在扩大对低收入人群的覆盖范围，而私人诊所和零售药局则获得了高利润的销售。

服务提供和取得模式正在改变人们的使用习惯。自新冠疫情爆发以来，远端医疗、电子商务和药房主导的配送服务促进了人们获取短效产品和咨询服务，降低了停药率，并提高了方法转换率；同时，社区分发和自我给药方案（例如，自行注射激素避孕药）增强了应对供应链中断的能力，并扩大了实际应用范围。这些配送创新也减少了年轻用户和都市区用户使用时的阻力，他们更倾向于选择隐密便捷的管道。

男性避孕药研发的快速进展是整个潜在市场的曲折点。包括非荷尔蒙植入和新型口服药物在内的多个临床计画在2024-2025年均报告了积极的早期结果和令人鼓舞的安全性数据。如果这些候选药物经过关键性临床试验和监管审批，男性避孕药有望在未来五到十年内显着扩大市场需求，并改变避孕药市场的模式。

最后，市场逆风和缓解因素至关重要。由于捐赠预算变化导致的采购不确定性、某些地区持续存在的未满足需求、新型器械面临的监管障碍以及来自价格更低的学名药的竞争，都可能挤压净利率并减缓产品普及速度。相反，亚太和拉丁美洲许多国家医疗保健预算的增长、供应链合作的加强以及私人商业化程度的提高，代表着短期内的利好因素，即使单位增长率较低，也能维持器械价值的增长。因此，分析师应建立多种情境模型（例如，长效可逆避孕方法的基准普及率、男性避孕方法加速进入市场以及捐赠资金减少），以了解器械收入的潜在增长和下降空间。

避孕器材市场面临许多製约和挑战，包括宗教反对和社会禁忌等社会和文化障碍，这些障碍限制了人们对避孕的公开讨论和使用。经济和物流问题也构成挑战。先进的避孕器械价格昂贵，在许多地区缺乏公共资金支持，导致很大一部分人群难以负担，而供应链不完善又阻碍了分销，使问题更加严重。此外，与健康相关的以及使用者自身的担忧，例如对副作用的担忧、缺乏准确资讯以及医护人员培训不足等，都可能导致避孕器械普及率低和滥用。最后，严格的监管流程以及过去因安全问题引发的诉讼遗留的不确定性，都可能延缓新产品的上市。

到2024年，保险套将占据全球避孕器产品市场最大的份额，约占全球避孕市场的55%。其主导地位主要归功于多种因素的综合作用，包括其易得性、双重防护性、消费行为。即便其他避孕方法日益普及，保险套的主导地位仍凸显了其作为计划生育基石产品的地位。

避孕器材市场区域分析

北美避孕器材市场趋势

预计北美将继续维持其作为避孕器材区域市场的主导地位，到2024年市场规模将达到91.1亿美元，市占率为41%。这一趋势得益于技术创新，例如开发更舒适、低剂量的器材以及与数位健康平台的整合。随着消费者对荷尔蒙类药物副作用的认识和担忧日益加深，对非荷尔蒙类避孕方法的需求也不断增长。儘管女性用避孕器市场正在多元化发展，但避孕套在男性避孕器仍然占据主导地位，由于其既能预防怀孕又能预防性传染感染的双重功能，因此仍保持着相当大的市场份额。

欧洲避孕器市场趋势

欧洲避孕器市场正经历稳定成长，预计到2024年将达到约50亿美元，年复合成长率（CAGR）为5.3%-5.4%。欧洲避孕器材市场是一个充满活力的产业，其发展趋势受到人们对长效可逆避孕方法（LARCs）日益增长的偏好，例如子宫内避孕器（IUD）和植入，这些方法因其高效性和便利性而广受欢迎。此外，越来越多的人希望避免荷尔蒙药物的副作用，因此对非荷尔蒙类避孕方法的需求不断增长，进一步推动了这一趋势。监管和政策支持也对市场产生了显着影响，许多欧洲国家政府为避孕措施提供补贴和报销，尤其是在年轻人群体中。儘管整体市场趋势是朝着更先进的方法发展，但区域差异显着，西欧和北欧的普及率高于东欧和南欧部分地区。

亚太地区避孕器市场趋势

亚太地区的避孕器市场正经历强劲成长，预计到2024年将创造约44.5亿美元的收入。亚太地区人口众多、都市化迅速，且社会经济格局不断变化，使其成为避孕器市场的主要成长引擎。该地区市场的发展趋势兼顾了满足未被满足的需求和采用现代有效的避孕方法。

亚太地区主要市场趋势

  • 积极的政府措施：该地区许多国家的政府，特别是像中国和印度这样的人口大国，长期以来都制定了控制人口成长的政策。这些政府透过公共卫生宣传活动和庞大的诊所网络积极推广计划生育，提供补助或免费的避孕药具。这种由上而下的支持是市场扩张的重要因素。
  • 意识提升与教育普及：教育的广泛普及、都市化的加快以及透过媒体和网路获取资讯的管道增多，提高了人们对性健康、生殖权利和计划生育益处的认识。这有助于打破围绕避孕的传统社会和文​​化禁忌，并提高避孕措施的采用率，尤其是在年轻一代。
  • 从传统方法到现代方法：由于对更有效的选择的需求，以及越来越多的女性希望控制怀孕间隔而不是永久停止生育，人们逐渐从传统的（例如，间歇性避孕和节律避孕）和永久性避孕方法转向了现代的、可逆的方法。

避孕器材市场的主要企业

以下列出了避孕器械市场的主要企业，这些参与者总合占据最大的市场份额，并引领着行业趋势。

  • Reckitt Benckiser Group PLC
  • Church & Dwight Co., Inc.
  • Organon & Co.
  • Bayer AG
  • CooperSurgical, Inc.
  • Mankind Pharma Ltd.
  • HLL Lifecare Limited
  • Karex Berhad
  • Okamoto Industries Inc.
  • Veru Inc.
  • Pregna International Limited
  • Kessel medintim GmbH
  • 其他的

避孕器市场充满活力，且呈现中等程度的分散化，既有大型跨国製药公司，也有专业公司。拜耳和套件洁时（杜蕾斯）等公司占据了相当大的市场份额，尤其是在荷尔蒙和保险套领域。但由于产品类型丰富多样，且各地区都有许多小型企业，因此市场集中度并不高。技术创新是推动市场竞争的动力，各公司竞相研发新一代长效可逆避孕方法（LARCs）以及副作用更少、使用更便捷的产品。此外，非荷尔蒙类和数位健康领域的竞争也日益激烈，新参与企业和创新新进者共同主导的市场格局。

避孕器市场的最新趋势

  • 2025 年 5 月，Famasys 的 FemBloc® 永久避孕系统获得了 CE 标誌核准，这是一种无需手术的门诊永久避孕装置和输送系统。
  • 2025年3月，NEXT生命科学公司宣布启动Plan A的临床试验。 Plan A是一种长效、可逆、不含荷尔蒙的男性避孕药。该产品被归类为医疗设备，使用可注射水凝胶过滤精子，药效可持续长达10年。
  • 2025 年 2 月，Church & Dwight 的 Ribbed Ecstasy 获得了 FDA 510(k) 许可。
  • 2025年2月，Sebela Women's Health Inc.的下一代无荷尔蒙铜子宫内避孕系统（IUS）MIUDELLA获得美国食品药物管理局（FDA）核准。这是40多年来美国首个核准的新型无激素子宫内避孕器。它采用柔韧的镍钛合金框架，铜含量不到目前市售铜子宫内避孕器的一半。
  • 2025年1月，在阿拉伯国际医疗器材展（Arab Health 2025）上，SMB公司推出了一款名为Silvee的新型银质子宫内避孕器。此节育器采用银质内芯，提高了耐用性和有效性，可提供长达五年的可靠避孕效果。

避孕器材市场区隔

  • 依避孕器材产品类型分類的暴露状况
  • 保险套
  • 隔膜
  • 子宫颈帽
  • 避孕环
  • 子宫内避孕器（IUD）
  • 皮下植入避孕药
  • 避孕装置的性别
  • 男性避孕器
  • 女性用避孕器
  • 避孕器械的通路
  • 医院药房
  • 零售药房
  • 线上药局和D2C平台
  • 大卖场和超级市场
  • 其他的
  • 避孕器械的区域趋势
  • 北美避孕器市场
  • 美国避孕器市场
  • 加拿大避孕器市场
  • 墨西哥避孕器材市场
  • 欧洲避孕器材市场
  • 英国避孕器材市场
  • 德国避孕器材市场
  • 法国避孕器材市场
  • 义大利避孕器材市场
  • 西班牙避孕器械市场
  • 其他欧洲避孕器材市场
  • 亚太地区避孕器材市场
  • 中国避孕器材市场
  • 日本避孕器材市场
  • 印度避孕器材市场
  • 澳洲避孕器材市场
  • 韩国避孕器材市场
  • 亚太地区其他避孕器材市场
  • 世界其他地区避孕器材市场
  • 南美洲避孕器材市场
  • 中东避孕器材市场
  • 非洲避孕器市场

影响分析

美国关税对避孕器械市场的影响分析：

美国对进口商品，特别是药品和医疗设备相关商品加征关税，正对全球避孕药市场产生重大且多方面的影响。这些关税推高了成本，迫使主要企业寻找替代供应商，扰乱了复杂的国际供应链，并可能导致全球范围内的生产延误和产品短缺。此类经济摩擦也可能引发其他国家的报復性关税，进一步推高商品价格，扰乱全球贸易。跨国公司将这些增加的成本转嫁给消费者，使得必要的避孕器，尤其是在开发中国家，变得更加难以负担和取得。此外，关税造成的财务不确定性可能迫使企业将研发资源重新分配到缓解供应链风险上，这可能会减缓创新步伐，推迟新技术在全球范围内的推出，最终颠覆国际製造业格局。

目录

第一章避孕器市场报告简介

第二章避孕器市场执行摘要

  • 市场概览

第三章避孕器市场关键因素分析

  • 市场驱动因素
    • 提高人们对计划生育的认识与需求
    • 技术进步与产品创新
    • 政府措施和资金
    • 人口结构和生活方式的变化
  • 市场限制与挑战
    • 与健康相关的挑战和使用者特定挑战
    • 社会、文化和宗教障碍
    • 监管和物流方面的障碍
  • 市场机会
    • 非荷尔蒙避孕与男性避孕的创新
    • 瞄准新兴经济体

第四章 影响分析

  • 美国关税的影响分析

第五章 监理分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第六章避孕器市场：波特五力分析

第七章避孕器市场评估

  • 依产品类型
  • 性别
  • 透过分销管道
  • 地区

第八章 竞争情势

第九章Start-Ups资金筹措与投资趋势

第十章避孕器市场 公司及产品概况

  • Reckitt Benckiser Group PLC
  • Church & Dwight Co., Inc.
  • Organon & Co.
  • Bayer AG
  • CooperSurgical, Inc.
  • Mankind Pharma Ltd.
  • HLL Lifecare Limited
  • Karex Berhad
  • Okamoto Industries Inc.
  • Veru Inc.
  • Pregna International Limited
  • Kessel medintim GmbH

第十一章：KOL视角

第十二章计划方法

第十三章：关于 DelveInsight

第十四章 免责声明和联络我们

Product Code: DIMDCL0450

Contraceptive Devices Market Summary

  • The global contraceptive devices market is expected to increase from USD 20,245.83 million in 2024 to USD 32,763.49 million by 2032, reflecting strong and sustained growth.
  • The global contraceptive devices market is growing at a CAGR of 6.28% during the forecast period from 2025 to 2032.
  • The global contraceptive devices market is growing due to several key factors. First, increased awareness and education about family planning are boosting demand. Second, demographic and lifestyle changes, such as delayed parenthood and the empowerment of women, are driving the need for effective solutions. Third, technological advancements, including the development of long-acting reversible contraceptives (LARCs) and products with fewer side effects, are attracting more users. Lastly, supportive government initiatives are making contraception more accessible and affordable, further fueling market expansion.
  • The leading companies operating in the contraceptive devices market include Reckitt Benckiser Group PLC, Church & Dwight Co., Inc., Organon & Co., Bayer AG, CooperSurgical, Inc., Mankind Pharma Ltd., HLL Lifecare Limited, Karex Berhad, Okamoto Industries Inc., Veru Inc., Pregna International Limited, Kessel medintim GmbH, and Others.
  • The North American contraceptive devices market is growing due to a rising preference for Long-Acting Reversible Contraceptives (LARCs) and non-hormonal options, driven by consumer demand for higher efficacy and fewer side effects. This trend is further supported by favorable government policies, such as the ACA, which has increased access by mandating insurance coverage. Additionally, the increasing integration of digital health and telehealth services is making information and prescriptions more accessible, particularly for a new generation of consumers.
  • In the product type segment of the contraceptive devices market, the condom category is estimated to account for the largest market share in 2024.

Factors Contributing to the Growth of the Contraceptive Devices Market

  • Increasing Awareness of Family Planning and Rising Demand for Contraceptives Fuelling Market Expansion: Increasing awareness of family planning and the rising demand for contraceptives are key drivers of market expansion, particularly in developing and emerging economies. This trend is fuelled by coordinated efforts from various stakeholders:
  • Government Initiatives: Many governments, especially in countries with high population growth, are implementing national family planning policies and programs. These initiatives often include educational campaigns to inform the public about the benefits of contraception for health and socioeconomic well-being. By making a wide range of contraceptive methods available and, in some cases, free or subsidized, governments are actively creating and satisfying demand.
  • NGOs and Public Health Organizations: Non-governmental organizations (NGOs) play a crucial role by providing community-based education and services, often reaching marginalized or rural populations that government programs may not fully serve. These organizations address cultural and social barriers, provide accurate information to dispel myths about side effects, and train healthcare workers to offer a wider choice of contraceptive methods.
  • Media and Digital Platforms: The proliferation of information through mass media, social media, and digital health applications is making knowledge about sexual and reproductive health more accessible than ever before. This increased access empowers individuals, especially young people, to make informed decisions about their health and family planning, leading to a higher adoption rate of modern contraceptive methods.
  • Socioeconomic Factors: As education levels rise and women gain more autonomy, there is a greater desire to delay or space pregnancies to pursue educational and career opportunities. This directly increases the demand for effective and reliable contraceptive methods. Similarly, a growing middle class in emerging markets has more disposable income to spend on modern, and often more expensive, forms of contraception, further driving market growth.
  • Technological Advancements and Product Innovation: Technological advancements and product innovation are key drivers of growth in the contraceptive devices market, as they address existing limitations and create new opportunities for both consumers and manufacturers.
  • Long-Acting Reversible Contraceptives (LARCs): There is a significant shift in consumer preference towards LARCs, such as IUDs and contraceptive implants, due to their high efficacy, convenience, and long-lasting protection. These devices reduce the need for daily or weekly attention, which is a major draw for many users.
  • Development of New Products: Manufacturers are investing in research and development to create innovative and user-friendly devices. This includes the introduction of custom-fit condoms, new hormonal and non-hormonal options, and ""smart"" devices that can be integrated with digital health platforms for monitoring.
  • Minimizing Side Effects: A key focus of new product development is to reduce common side effects associated with hormonal contraception, such as weight gain, headaches, and menstrual changes. This is attracting a new segment of users who are concerned about these issues.
  • Government Initiatives and Funding: Many governments, especially in countries with high population growth, are implementing national family planning policies and programs. These initiatives often include educational campaigns to inform the public about the benefits of contraception for health and socioeconomic well-being.
  • National Population Control Policies: In many countries, particularly in Asia and Africa, governments are implementing policies and programs aimed at population control and stabilization. These initiatives often include subsidies and free distribution of contraceptive devices, thereby increasing their accessibility and affordability.
  • Healthcare Support: Government-backed healthcare programs, like the National Health Mission in India, are making contraception an integral part of their public health strategy. This includes training healthcare workers to provide family planning counseling and services, including the insertion of IUDs.
  • Public-Private Partnerships: Governments and NGOs are increasingly collaborating with the private sector to expand the reach of family planning services, ensuring that contraceptives are available in both urban and rural areas through a variety of channels, including public clinics, private pharmacies, and community-level health workers.

Contraceptive Devices Market Report Segmentation

This contraceptive devices market report offers a comprehensive overview of the global contraceptive devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (Condom, Diaphragms, Cervical Cap, Vaginal Rings, Intrauterine Device (IUD), and Sub Dermal Contraceptive Implants), Gender (Male Contraceptive Devices, Female Contraceptive Devices), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies and D2C Platforms, Hypermarkets and Supermarkets, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing contraceptive devices market.

A contraceptive device, also known as a form of birth control, is a device or preparation designed to prevent pregnancy. These devices work in various ways, such as creating a physical barrier to block sperm, releasing hormones to inhibit ovulation, or making the uterine environment inhospitable to sperm or fertilized eggs.

The global contraceptive devices market is growing due to several key factors. First, increased awareness and education about family planning and reproductive health, driven by public health campaigns and a greater focus on preventing unintended pregnancies and sexually transmitted infections (STIs), is boosting demand. Second, demographic and lifestyle changes are playing a major role; trends such as delayed parenthood, the empowerment of women, and an increasing emphasis on shared responsibility for family planning are driving the need for effective contraceptive solutions. Third, technological advancements and product innovation, including the development of highly effective long-acting reversible contraceptives (LARCs) like IUDs and implants, as well as products with fewer side effects, are attracting more users. Lastly, supportive government initiatives and funding in many countries are making contraception more accessible and affordable through public health programs and subsidies, further fueling market expansion.

What are the latest Contraceptive Devices Market Dynamics and Trends?

The global contraceptive devices market is projected to expand at a robust compound annual growth rate (CAGR) of approximately 6.8% during the forecast period of 2025 to 2032, driven by rising LARC uptake, broader public-sector procurement, and growing private-sector demand in APAC and LATAM.

A primary structural driver is the continuing shift toward long-acting reversible contraceptives (LARCs), modern IUDs, and subdermal implants, which are displacing (or supplementing) short-acting, user-dependent methods in many markets because of superior efficacy, convenience, and improved clinician familiarity. Procurement and shipment data show notable year-on-year increases in LARC supplies (copper IUD and implant procurement rose in recent public-sector cycles), which raises the market's value even when unit volumes are stable because LARCs command higher per-patient revenue and longer duration of protection.

Public procurement, donor programs, and government family-planning initiatives remain foundational to volume growth. Large multilateral and bilateral suppliers (including UNFPA partnerships) continue to supply billions of units of condoms and substantial volumes of implants/IUDs to low- and middle-income countries; UNFPA and related partnerships reported large-scale distribution and support for government procurement in 2023-2024, which both fills unmet need and creates visible demand that attracts manufacturers and investors. At the same time, tiered pricing and social-marketing channels are expanding reach into lower-income segments while private clinics and retail pharmacies capture higher-margin sales.

Service delivery and access models are changing the use pattern: telehealth, e-commerce, and pharmacy-led provision have made short-acting products and counselling easier to access since COVID-19, reducing discontinuation and improving method switching; meanwhile, community distribution and self-administered options (e.g., self-injectable for hormonal contraception) have hardened the resilience of supply chains against disruptions and expanded real-world uptake. These delivery innovations also lower the friction for young and urban users who prefer discreet, convenient channels.

A potential inflection point for total addressable market size is the rapid progress in male-contraception R&D. Multiple clinical programs, including non-hormonal implants and novel oral agents, reported positive early results or encouraging safety data in 2024 - 2025; if these candidates advance through pivotal trials and regulatory review, male methods could materially expand demand and shift method mixes over the next 5-10 years.

Finally, market headwinds and moderating factors matter: procurement volatility when donor budgets shift, persistent unmet need in certain geographies, regulatory hurdles for novel devices, and competition from cheaper generic options can compress margins or delay uptake. Conversely, rising health budgets in many APAC and LATAM countries, stronger supply-chain coordination, and active private-sector commercialization are near-term tailwinds that sustain growth in device value even where unit growth is incremental. Analysts should therefore model multiple scenarios (baseline adoption of LARCs, accelerated male-method entry, and donor-funding contraction) to capture the plausible upside and downside to device revenues.

The contraceptive devices market faces significant restraints and challenges, including social and cultural barriers like religious opposition and societal taboos that limit open discussion and use of contraception. Economic and logistical issues also pose a challenge, as the high cost of advanced devices and a lack of public funding in many regions make them inaccessible to large populations, compounded by poor supply chains that hinder distribution. Furthermore, health-related and user-specific concerns like perceived side effects, a lack of accurate information, and insufficient training for healthcare providers can lead to low adoption rates and incorrect usage. Finally, stringent regulatory processes and the lingering fear from past litigation over safety issues can delay the introduction of new products to the market.

Contraceptive Devices Market Segment Analysis

Contraceptive Devices Market by Product Type (Condom, Diaphragms, Cervical Cap, Vaginal Rings, Intrauterine Device (IUD), and Sub Dermal Contraceptive Implants), Gender (Male Contraceptive Devices, Female Contraceptive Devices), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies and D2C Platforms, Hypermarkets and Supermarkets, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

By Product Type: Condom Category Dominates the Market

In 2024, the condom product type held the largest share, commanding approximately 55% of the global contraceptive devices market. This dominance is primarily attributed to a combination of factors related to accessibility, dual protection, and consumer behavior. This dominance highlights condoms as a foundational product in the family planning landscape, even as other methods gain traction.

Key Insights into Condom Market Dominance:

  • Dual Protection: Condoms are the only widely available contraceptive device that offers dual protection against both unintended pregnancy and sexually transmitted infections (STIs), including HIV. This dual benefit makes them a critical public health tool and a preferred choice for individuals who are not in monogamous relationships or who prioritize STI prevention.
  • Accessibility and Affordability: Condoms are generally the most affordable and accessible contraceptive method. They can be purchased without a prescription from a wide variety of locations, including pharmacies, supermarkets, convenience stores, and online retailers. This widespread availability, combined with their low cost, makes them a go-to option, especially in developing countries.
  • Widespread Use in Public Health Programs: Governments and NGOs worldwide actively promote and distribute condoms, often for free or at heavily subsidized prices. These public health initiatives, particularly in regions with high rates of HIV/AIDS and other STIs, contribute significantly to condom market volume and help to normalize their use.
  • User-Controlled and Non-Invasive: Unlike many other methods like IUDs or implants, condoms are non-invasive, and their use is entirely user-controlled. This gives individuals a sense of autonomy and control over their reproductive health decisions. The fact that they can be used on demand, without a long-term commitment, appeals to a wide range of consumers.
  • Product Innovation and Marketing: While condoms have been around for a long time, the market is continually innovating to improve the user experience. This includes a wide range of products with different materials (latex-free options for allergies), textures, flavors, and sizes. Sophisticated marketing campaigns also help to destigmatize their use and appeal to modern consumer preferences, particularly among young adults.

Despite the growing popularity and high effectiveness of long-acting reversible contraceptives (LARCs) like IUDs and implants, condoms' unique benefits in terms of dual protection, accessibility, and user control ensure their continued dominant position in the global market.

By Gender: Male Contraceptive Devices Dominate the Market

The dominance of male contraceptive devices, specifically male condoms, in the global market is driven by a unique combination of factors. The primary reason for their commanding 55% share of the market revenue in 2024 is their dual-purpose functionality; condoms are the only widely available contraceptive device that provides effective protection against both unintended pregnancy and sexually transmitted infections (STIs), including HIV. This makes them an essential tool for public health and a top choice for individuals seeking comprehensive protection. Furthermore, condoms are highly accessible and affordable, requiring no prescription and being sold in a vast range of retail locations, from pharmacies to convenience stores, which ensures widespread availability, especially in low-income regions.

Global public health campaigns by governments and NGOs also heavily promote and distribute condoms to combat STIs, significantly boosting sales volume. Lastly, their user-controlled and non-invasive nature appeals to consumers who prefer a method that doesn't involve long-term commitment or potential side effects associated with hormonal methods or surgical procedures. These combined factors, dual protection, accessibility, affordability, and user control, ensure that male condoms continue to dominate the contraceptive devices market, even with the rise of newer, high-tech alternatives.

By Distribution Channel: Retail Pharmacy Category Dominates the Market

Retail pharmacies maintained a dominant market share in the contraceptive devices market in 2024, holding approximately 40% of the revenue. This is primarily due to their broad geographic reach and the immediate availability of products, allowing consumers to get what they need quickly and in person. However, the online and Direct-to-Consumer (D2C) channel is growing at a robust rate. This growth is driven by consumer preferences for discretion and privacy, the convenience of ordering products from home, and the increasing integration of telehealth services for prescriptions. While retail pharmacies will remain a key channel for their established trust and physical presence, the online/D2C channel is rapidly expanding by offering a more private, convenient, and often more affordable shopping experience, suggesting a future market shaped by a hybrid of both physical and digital retail models.

Contraceptive Devices Market Regional Analysis

North America Contraceptive Devices Market Trends

North America is projected to maintain its position as the dominant regional market for contraceptive devices, with a significant market share of 41% in 2024 valued at USD 9.11 billion, driven by a growing preference for Long-Acting Reversible Contraceptives (LARCs) like IUDs and implants due to their high efficacy and convenience. This trend is supported by technological innovation, which is focused on creating more comfortable, lower-dose devices and integrating with digital health platforms. The market is also seeing a rising demand for non-hormonal options as consumers become more aware of and concerned about the side effects of hormonal methods. While the market for female devices is diversifying, the male contraceptive segment, dominated by condoms, maintains a significant share due to their dual function of preventing both pregnancy and STIs. The market is further shaped by supportive healthcare policies and a nascent but growing trend of investment in new male contraceptive research and development.

Europe Contraceptive Devices Market Trends

The Europe contraceptive devices market is experiencing steady growth, generating about USD 5 billion in 2024, growing at a CAGR of 5.3-5.4%. The European contraceptive devices market is a dynamic sector shaped by a growing preference for Long-Acting Reversible Contraceptives (LARCs), like IUDs and implants, which are gaining popularity due to their high efficacy and convenience. This trend is further fueled by a rising demand for non-hormonal options, as a segment of the population seeks to avoid the side effects of hormonal methods. The market is also heavily influenced by a supportive regulatory and policy landscape, with many European governments providing subsidies and reimbursement for contraception, particularly for young people. While the overall market is trending toward more advanced methods, there are significant regional differences, with higher adoption rates in Western and Northern Europe compared to some parts of Eastern and Southern Europe. Additionally, the increasing integration of digital and telehealth solutions is making it easier for consumers to access information and prescriptions, which is a growing driver for the market.

Asia-Pacific Contraceptive Devices Market Trends

The Asia-Pacific contraceptive devices market is experiencing robust growth, generating about USD 4.45 billion in revenue in 2024. The Asia-Pacific region is a major growth engine for the contraceptive devices market, driven by its large population, rapid urbanization, and evolving socioeconomic landscape. The market trends in this diverse region are a mix of addressing unmet needs and adopting modern, effective methods.

Key Market Trends in Asia-Pacific

  • Proactive Government Initiatives: Many governments in the region, particularly in populous countries like China and India, have long-standing policies to manage population growth. These governments actively promote family planning through public health campaigns and a vast network of health clinics that provide subsidized or free contraceptive devices. This top-down support is a major driver of market expansion.
  • Rising Awareness and Education: The increasing prevalence of education, urbanization, and access to information through media and the internet is raising awareness about sexual health, reproductive rights, and the benefits of family planning. This is helping to break down traditional social and cultural taboos surrounding contraception, leading to higher adoption rates, especially among younger generations.
  • Shift from Traditional to Modern Methods: While traditional methods (like withdrawal or rhythm) and permanent sterilization have been common, there is a gradual but significant shift toward modern, reversible methods. This is driven by a desire for more effective options and a growing number of women who want to space pregnancies rather than stop childbearing permanently.

Who are the major players in the Contraceptive Devices Market?

The following are the leading companies in the contraceptive devices market. These companies collectively hold the largest market share and dictate industry trends.

  • Reckitt Benckiser Group PLC
  • Church & Dwight Co., Inc.
  • Organon & Co.
  • Bayer AG
  • CooperSurgical, Inc.
  • Mankind Pharma Ltd.
  • HLL Lifecare Limited
  • Karex Berhad
  • Okamoto Industries Inc.
  • Veru Inc.
  • Pregna International Limited
  • Kessel medintim GmbH
  • Others

How is the competitive landscape shaping the Contraceptive Devices Market?

The competitive landscape of the contraceptive devices market is dynamic and moderately fragmented, with a mix of multinational pharmaceutical giants and specialized players. While companies like Bayer and Reckitt Benckiser (Durex) hold significant market share, particularly in the hormonal and condom segments, respectively, the market is not highly concentrated due to the variety of product types and the presence of numerous smaller, regional companies. Competition is driven by a focus on technological innovation, with companies racing to develop next-generation LARCs (Long-Acting Reversible Contraceptives) and more user-friendly products with fewer side effects. Additionally, there is a growing competitive dynamic in the non-hormonal and digital health segments, as new entrants and established players alike seek to capture market share by addressing consumer concerns about hormones and leveraging new technologies. This environment fosters a continuous cycle of product development, strategic partnerships, and mergers and acquisitions, ultimately shaping a market defined by a blend of established leaders and innovative newcomers.

Recent Developmental Activities in the Contraceptive Devices Market

  • In May 2025, Femasys received CE Mark approval for its in-office, non-surgical permanent contraception device and delivery system, FemBloc(R) Permanent Birth Control System.
  • In March 2025, NEXT Life Sciences announced the launch of clinical trials for Plan A, a long-lasting, reversible, and hormone-free male contraceptive. The product, which is classified as a medical device, uses an injectable hydrogel to filter out sperm for up to 10 years.
  • In February 2025, FDA 510(k) clearance for Church & Dwight's ribbed Ecstasy variant.
  • In February 2025, Sebela Women's Health Inc. received FDA approval for MIUDELLA, a next-generation, hormone-free copper intrauterine system (IUS). It is the first new hormone-free IUD to be approved in the U.S. in over 40 years. It uses a flexible nitinol frame and less than half the copper of the currently available copper IUD.
  • In January 2025, at Arab Health 2025, SMB Corporation unveiled the Silvee, a new silver IUD. The device features a silver core to enhance durability and effectiveness, providing up to five years of reliable contraception.

Contraceptive Devices Market Segmentation

  • Contraceptive Devices Product Type Exposure
  • Condom
  • Diaphragms
  • Cervical Cap
  • Vaginal Rings
  • Intrauterine Device (IUD)
  • Sub Dermal Contraceptive Implants
  • Contraceptive Devices Gender Exposure
  • Male Contraceptive Devices
  • Female Contraceptive Devices
  • Contraceptive Devices Distribution Channel Exposure
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacies and D2C Platforms
  • Hypermarkets and Supermarkets
  • Others
  • Contraceptive Devices Geography Exposure
  • North America Contraceptive Devices Market
  • United States Contraceptive Devices Market
  • Canada Contraceptive Devices Market
  • Mexico Contraceptive Devices Market
  • Europe Contraceptive Devices Market
  • United Kingdom Contraceptive Devices Market
  • Germany Contraceptive Devices Market
  • France Contraceptive Devices Market
  • Italy Contraceptive Devices Market
  • Spain Contraceptive Devices Market
  • Rest of Europe Contraceptive Devices Market
  • Asia-Pacific Contraceptive Devices Market
  • China Contraceptive Devices Market
  • Japan Contraceptive Devices Market
  • India Contraceptive Devices Market
  • Australia Contraceptive Devices Market
  • South Korea Contraceptive Devices Market
  • Rest of Asia-Pacific Contraceptive Devices Market
  • Rest of the World Contraceptive Devices Market
  • South America Contraceptive Devices Market
  • Middle East Contraceptive Devices Market
  • Africa Contraceptive Devices Market

Impact Analysis

U.S. Tariff Impact Analysis on the Contraceptive Devices Market:

The implementation of U.S. tariffs on imported goods, particularly those related to pharmaceuticals and medical devices, has a significant and multifaceted impact on the global contraceptive devices market. These tariffs disrupt the complex international supply chain by increasing costs and forcing companies to find alternative suppliers, which can lead to production delays and product shortages worldwide. This economic friction can also trigger retaliatory tariffs from other countries, further raising the cost of goods and hindering global trade. As multinational companies pass these increased costs onto consumers, essential contraceptives become less affordable, particularly in developing countries. Furthermore, the financial uncertainty caused by tariffs may compel companies to divert resources from research and development toward mitigating supply chain risks, which could slow the pace of innovation and delay the launch of new technologies globally, ultimately reshaping the international manufacturing landscape.

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the contraceptive devices market report study

  • Market size analysis for the current contraceptive devices market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the contraceptive devices market.
  • Various opportunities available for the other competitors in the contraceptive devices market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current contraceptive devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the contraceptive devices market growth in the future?

Frequently Asked Questions for the Contraceptive Devices Market

1. What is the growth rate of the contraceptive devices market?

  • The contraceptive devices market is estimated to grow at a CAGR of 6.28% during the forecast period from 2025 to 2032.

2. What is the market for contraceptive devices?

  • The contraceptive devices market was valued at USD 20,245.83 million in 2024, and is expected to reach USD 32,763.49 million by 2032.

3. Which region has the highest share in the contraceptive devices market?

  • The North American contraceptive devices market is growing due to a rising preference for Long-Acting Reversible Contraceptives (LARCs) and non-hormonal options, driven by consumer demand for higher efficacy and fewer side effects. This trend is further supported by favorable government policies, such as the ACA, which has increased access by mandating insurance coverage. Additionally, the increasing integration of digital health and telehealth services is making information and prescriptions more accessible, particularly for a new generation of consumers.

4. What are the drivers for the contraceptive devices market?

  • The global contraceptive devices market is growing due to several key factors. First, increased awareness and education about family planning are boosting demand. Second, demographic and lifestyle changes, such as delayed parenthood and the empowerment of women, are driving the need for effective solutions. Third, technological advancements, including the development of long-acting reversible contraceptives (LARCs) and products with fewer side effects, are attracting more users. Lastly, supportive government initiatives are making contraception more accessible and affordable, further fueling market expansion.

5. Who are the key players operating in the contraceptive devices market?

  • Some of the key market players operating in the contraceptive devices market include Reckitt Benckiser Group PLC, Church & Dwight Co., Inc., Organon & Co., Bayer AG, CooperSurgical, Inc., Mankind Pharma Ltd., HLL Lifecare Limited, Karex Berhad, Okamoto Industries Inc., Veru Inc., Pregna International Limited, Kessel medintim GmbH, and Others.

Table of Contents

1. Contraceptive Devices Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Contraceptive Devices Market Executive Summary

  • 2.1 Market at Glance

3. Contraceptive Devices Market Key Factors Analysis

  • 3.1 Contraceptive Devices Market Drivers
    • 3.1.1 Rising Awareness and Demand for Family Planning
    • 3.1.2 Technological Advancements and Product Innovation
    • 3.1.3 Government Initiatives and Funding
    • 3.1.4 Demographic and Lifestyle Changes
  • 3.2 Contraceptive Devices Market Restraints and Challenges
    • 3.2.1 Health-Related and User-Specific Challenges
    • 3.2.2 Social, Cultural, and Religious Barriers
    • 3.2.3 Regulatory and Logistical Hurdles
  • 3.3 Contraceptive Devices Market Opportunity
    • 3.3.1 Innovation in Non-Hormonal and Male Contraception
    • 3.3.2 Targeting Emerging Economies

4. Impact Analysis

  • 4.1 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Contraceptive Devices Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Contraceptive Devices Market Assessment

  • 7.1 By Product Type
    • 7.1.1 Condom
    • 7.1.2 Diaphragms
    • 7.1.3 Cervical Cap
    • 7.1.4 Vaginal Rings
    • 7.1.5 Intrauterine Device (IUD)
    • 7.1.6 Sub Dermal Contraceptive Implants
  • 7.2 By Gender
    • 7.2.1 Male Contraceptive Devices
    • 7.2.2 Female Contraceptive Devices
  • 7.3 By Distribution Channel
    • 7.3.1 Hospital Pharmacy
    • 7.3.2 Retail Pharmacy
    • 7.3.3 Online Pharmacies and D2C Platforms
    • 7.3.4 Hypermarkets and Supermarkets
    • 7.3.5 Others
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 United States Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.1.2 Canada Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.1.3 Mexico Contraceptive Devices Market Size in USD million (2022-2032)
    • 7.4.2 Europe
      • 7.4.2.1 France Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.2.2 Germany Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.2.3 United Kingdom Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.2.4 Italy Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.2.5 Spain Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.2.6 Rest of Europe Contraceptive Devices Market Size in USD million (2022-2032)
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 China Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.3.2 Japan Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.3.3 India Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.3.4 Australia Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.3.5 South Korea Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.3.6 Rest of Asia-Pacific Contraceptive Devices Market Size in USD million (2022-2032)
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 Middle East Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.4.2 Africa Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.4.3 South America Contraceptive Devices Market Size In USD Million (2022-2032)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Contraceptive Devices Market Company and Product Profiles

  • 10.1 Reckitt Benckiser Group PLC
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Listing
    • 10.1.5 Entropy
  • 10.2 Church & Dwight Co., Inc.
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Listing
    • 10.2.5 Entropy
  • 10.3 Organon & Co.
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Listing
    • 10.3.5 Entropy
  • 10.4 Bayer AG
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Listing
    • 10.4.5 Entropy
  • 10.5 CooperSurgical, Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Listing
    • 10.5.5 Entropy
  • 10.6 Mankind Pharma Ltd.
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Listing
    • 10.6.5 Entropy
  • 10.7 HLL Lifecare Limited
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Listing
    • 10.7.5 Entropy
  • 10.8 Karex Berhad
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Listing
    • 10.8.5 Entropy
  • 10.9 Okamoto Industries Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Listing
    • 10.9.5 Entropy
  • 10.10 Veru Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Listing
    • 10.10.5 Entropy
  • 10.11 Pregna International Limited
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Financial Overview
    • 10.11.4 Product Listing
    • 10.11.5 Entropy
  • 10.12 Kessel medintim GmbH
    • 10.12.1 Company Overview
    • 10.12.2 Company Snapshot
    • 10.12.3 Financial Overview
    • 10.12.4 Product Listing
    • 10.12.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us

List of Tables

  • Table 1: Contraceptive Devices Market in Global (2022-2032)
  • Table 2: Contraceptive Devices Market in Global by Product Type (2022-2032)
  • Table 3: Contraceptive Devices Market in Global by Gender (2022-2032)
  • Table 4: Contraceptive Devices Market in Global by Distribution Channel (2022-2032)
  • Table 5: Contraceptive Devices Market in Global by Geography (2022-2032)
  • Table 6: Contraceptive Devices Market in North America (2022-2032)
  • Table 7: Contraceptive Devices Market in the United States (2022-2032)
  • Table 8: Contraceptive Devices Market in Canada (2022-2032)
  • Table 9: Contraceptive Devices Market in Mexico (2022-2032)
  • Table 10: Contraceptive Devices Market in Europe (2022-2032)
  • Table 11: Contraceptive Devices Market in France (2022-2032)
  • Table 12: Contraceptive Devices Market in Germany (2022-2032)
  • Table 13: Contraceptive Devices Market in United Kingdom (2022-2032)
  • Table 14: Contraceptive Devices Market in Italy (2022-2032)
  • Table 15: Contraceptive Devices Market in Spain (2022-2032)
  • Table 16: Contraceptive Devices Market in the Rest of Europe (2022-2032)
  • Table 17: Contraceptive Devices Market in Asia-Pacific (2022-2032)
  • Table 18: Contraceptive Devices Market in China (2022-2032)
  • Table 19: Contraceptive Devices Market in Japan (2022-2032)
  • Table 20: Contraceptive Devices Market in India (2022-2032)
  • Table 21: Contraceptive Devices Market in Australia (2022-2032)
  • Table 22: Contraceptive Devices Market in South Korea (2022-2032)
  • Table 23: Contraceptive Devices Market in Rest of Asia-Pacific (2022-2032)
  • Table 24: Contraceptive Devices Market in the Rest of the World (2022-2032)
  • Table 25: Contraceptive Devices Market in the Middle East (2022-2032)
  • Table 26: Contraceptive Devices Market in Africa (2022-2032)
  • Table 27: Contraceptive Devices Market in South America (2022-2032)
  • Table 28: Competitive Landscape
  • Table 29: Startup Funding & Investment Trends

List of Figures

  • Figure 1: Contraceptive Devices Market Drivers
  • Figure 2: Contraceptive Devices Market Restraints
  • Figure 3: Contraceptive Devices Market Opportunities
  • Figure 4: AI-Powered Innovations in the Contraceptive Devices Market
  • Figure 5: US Tariff Impact on Contraceptive Devices Market
  • Figure 6: Regulatory Analysis (US, EU, Japan, China)
  • Figure 7: Porter's Five Forces Analysis
  • Figure 8: Competitive Analysis
  • Figure 9: Contraceptive Devices Market in Global (2022-2032)
  • Figure 10: Contraceptive Devices Market in Global by Product Type (2022-2032)
  • Figure 11: Contraceptive Devices Market in Global by Gender (2022-2032)
  • Figure 12: Contraceptive Devices Market in Global by Distribution Channel (2022-2032)
  • Figure 13: Contraceptive Devices Market in Global by Geography (2022-2032)
  • Figure 14: Contraceptive Devices Market in North America (2022-2032)
  • Figure 15: Contraceptive Devices Market in the United States (2022-2032)
  • Figure 16: Contraceptive Devices Market in Canada (2022-2032)
  • Figure 17: Contraceptive Devices Market in Mexico (2022-2032)
  • Figure 18: Contraceptive Devices Market in Europe (2022-2032)
  • Figure 19: Contraceptive Devices Market in France (2022-2032)
  • Figure 20: Contraceptive Devices Market in Germany (2022-2032)
  • Figure 21: Contraceptive Devices Market in United Kingdom (2022-2032)
  • Figure 22: Contraceptive Devices Market in Italy (2022-2032)
  • Figure 23: Contraceptive Devices Market in Spain (2022-2032)
  • Figure 24: Contraceptive Devices Market in the Rest of Europe (2022-2032)
  • Figure 25: Contraceptive Devices Market in Asia-Pacific (2022-2032)
  • Figure 26: Contraceptive Devices Market in China (2022-2032)
  • Figure 27: Contraceptive Devices Market in Japan (2022-2032)
  • Figure 28: Contraceptive Devices Market in India (2022-2032)
  • Figure 29: Contraceptive Devices Market in Australia (2022-2032)
  • Figure 30: Contraceptive Devices Market in South Korea (2022-2032)
  • Figure 31: Contraceptive Devices Market in Rest of Asia-Pacific (2022-2032)
  • Figure 32: Contraceptive Devices Market in the Rest of the World (2022-2032)
  • Figure 33: Contraceptive Devices Market in the Middle East (2022-2032)
  • Figure 34: Contraceptive Devices Market in Africa (2022-2032)
  • Figure 35: Contraceptive Devices Market in South America (2022-2032)
  • Figure 36: Competitive Landscape
  • Figure 37: Startup Funding & Investment Trends